Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    02958930
Previous Study | Return to List | Next Study

Safety and Efficacy of Transcranial Electromagnetic Treatment Against Alzheimer's Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02958930
Recruitment Status : Completed
First Posted : November 8, 2016
Last Update Posted : April 23, 2019
Sponsor:
Collaborators:
Byrd Alzheimer's Institute, University of South Florida
University Diagnostic Institute, Tampa
Invicro, Boston
Left Coast Engineering, Escondido
Information provided by (Responsible Party):
NeuroEM Therapeutics, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : January 4, 2019
Actual Study Completion Date : January 11, 2019
Publications:
Mori T, Arendash GW. Electromagnetic field treatment enhances neuronal activity: Linkage to cognitive benefit and therapeutic implications for Alzheimer's Disease. J Alzheimer's Dis and Parkinsonism 2011: Vol. 1:102, http://dx.doi.org/10.4172/2161-0460.1000102.